Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR Pharma Following Positive Phase 2a Proof-of-Concept Study Read more
Biogen Plans Regulatory Filing for Aducanumab in Alzheimer’s Disease Based on New Analysis of Larger Dataset from Phase 3 Studies Read more
Odonate Therapeutics announces completion of enrollment in CONTESSA metastatic breast cancer trial Read more
Knight Therapeutics to Acquire Grupo Biotoscana, Establishing a Latin American Growth Platform Read more
Farxiga approved in the US to reduce the risk of hospitalisation for heart failure in patients with type-2 diabetes Read more
Verseau Launches with $50 Million to Develop First-in-Class Macrophage-Targeted Immunotherapies and Appoints George Golumbeski as Chairman of the Board Read more
Janssen Announces FDA Approval of STELARA (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis Read more